Digoxin Tablets, USP

About Jerome Stevens Pharmaceuticals

Jerome Stevens Pharmaceuticals is a niche, vertically-integrated generic drug manufacturer with a strong legacy in complex generic formulations. The company's core value proposition is an unwavering commitment to product quality over portfolio breadth, a stance it maintains as a family-owned operation. Its historic achievement was securing the first New Drug Application (NDA) approval for levothyroxine sodium (UNITHROID®) in 2000, establishing a durable branded presence within a large generic market. JSP's commercial focus remains on its two key products, UNITHROID® and Digoxin, distributed in the United States through a partnership with a major pharmaceutical distributor.

Therapeutic Areas